Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Medicine and Society Feb 2021 Health Equity and the Circle of Human Concern john a. powell, JD and Eloy Toppin, Jr, MPP Being marked as an “other” outside of the circle of human concern expresses tension between principles of liberty and equality and exacerbates health inequity. AMA J Ethics. 2021;23(2):E166-174. doi: 10.1001/amajethics.2021.166. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Medicine and Society Feb 2021 Health Equity and the Circle of Human Concern john a. powell, JD and Eloy Toppin, Jr, MPP Being marked as an “other” outside of the circle of human concern expresses tension between principles of liberty and equality and exacerbates health inequity. AMA J Ethics. 2021;23(2):E166-174. doi: 10.1001/amajethics.2021.166.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.